Literature DB >> 19263497

GFP-p65 knock-in mice as a tool to study NF-kappaB dynamics in vivo.

Rossana De Lorenzi1, Ralph Gareus, Sven Fengler, Manolis Pasparakis.   

Abstract

The nuclear factor kappaB (NF-kappaB) signaling pathway regulates immune and inflammatory responses and is implicated in the pathogenesis of multiple diseases. The principal mechanism controlling NF-kappaB activation depends on the association of NF-kappaB transcription factor dimers with IkappaB molecules, which prevents the accumulation of NF-kappaB in the nucleus and the activation of target gene transcription. Monitoring the nucleocytoplalsmic shuttling of NF-kappaB factors is a reliable method to study the dynamic regulation of NF-kappaB activity. Here, we generated knock-in mice expressing a fusion protein between the green fluorescent protein (GFP) and the p65/RelA NF-kappaB subunit (GFP-p65) from the endogenous p65 genomic locus. Homozygous GFP-p65 mice developed normally and showed normal NF-kappaB activation, demonstrating that the GFP-p65 fusion protein functionally substitutes for wild-type p65. Live imaging of primary cells from GFP-p65 mice allowed real-time monitoring of p65 nucleocytoplasmic shuttling upon NF-kappaB activation. Therefore, the GFP-p65 knock-in mice constitute an invaluable tool for studying the dynamic regulation of NF-kappaB. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19263497     DOI: 10.1002/dvg.20468

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  31 in total

1.  An investigation of the specificity of research antibodies against NF-κB-subunit p65.

Authors:  Carsten Slotta; Janine Müller; Loan Tran; Stefan Hauser; Darius Widera; Barbara Kaltschmidt; Christian Kaltschmidt
Journal:  J Histochem Cytochem       Date:  2013-11-19       Impact factor: 2.479

2.  Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis.

Authors:  Jimmy L Zhao; Chao Ma; Ryan M O'Connell; Arnav Mehta; Race DiLoreto; James R Heath; David Baltimore
Journal:  Cell Stem Cell       Date:  2014-02-20       Impact factor: 24.633

3.  EGF-induced dynamics of NF-κB and F-actin in A431 cells spread on fibronectin.

Authors:  Anastasia Bolshakova; Karl-Eric Magnusson; George Pinaev; Olga Petukhova
Journal:  Histochem Cell Biol       Date:  2015-05-20       Impact factor: 4.304

4.  Measurement of NF-κB Activation in TLR-Activated Macrophages.

Authors:  Orna Ernst; Sharat J Vayttaden; Iain D C Fraser
Journal:  Methods Mol Biol       Date:  2018

Review 5.  Redefining Signaling Pathways with an Expanding Single-Cell Toolbox.

Authors:  Suzanne Gaudet; Kathryn Miller-Jensen
Journal:  Trends Biotechnol       Date:  2016-03-09       Impact factor: 19.536

Review 6.  High-throughput, single-cell NF-κB dynamics.

Authors:  Timothy K Lee; Markus W Covert
Journal:  Curr Opin Genet Dev       Date:  2010-09-16       Impact factor: 5.578

7.  Single-cell analyses reveal an attenuated NF-κB response in the Salmonella-infected fibroblast.

Authors:  Estel Ramos-Marquès; Samuel Zambrano; Alberto Tiérrez; Marco E Bianchi; Alessandra Agresti; Francisco García-Del Portillo
Journal:  Virulence       Date:  2016-08-30       Impact factor: 5.882

8.  Targeting of NF-κB to Dendritic Spines Is Required for Synaptic Signaling and Spine Development.

Authors:  Erica C Dresselhaus; Matthew C H Boersma; Mollie K Meffert
Journal:  J Neurosci       Date:  2018-03-19       Impact factor: 6.167

9.  A noisy paracrine signal determines the cellular NF-kappaB response to lipopolysaccharide.

Authors:  Timothy K Lee; Elissa M Denny; Jayodita C Sanghvi; Jahlionais E Gaston; Nathaniel D Maynard; Jacob J Hughey; Markus W Covert
Journal:  Sci Signal       Date:  2009-10-20       Impact factor: 8.192

10.  Sustained oscillations of NF-kappaB produce distinct genome scanning and gene expression profiles.

Authors:  Myong-Hee Sung; Luigi Salvatore; Rossana De Lorenzi; Anindya Indrawan; Manolis Pasparakis; Gordon L Hager; Marco E Bianchi; Alessandra Agresti
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.